Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool

Ghana Health Technology Assessment Technical Working Group

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Background: This study estimated cost of COVID-19 vaccine introduction and deployment in Ghana. Methods: Using the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool Ghana's Ministry of Health Technical Working Group for Health Technology Assessment (TWG-HTA) in collaboration with School of Public Health, University of Ghana, organized an initial two-day workshop that brought together partners to deliberate and agree on input parameters to populate the CVIC tool. A further 2–3 days validation with the Expanded Program of Immunization (EPI) and other partners to finalize the analysis was done. Three scenarios, with different combinations of vaccine products and delivery modalities, as well as time period were analyzed. The scenarios included AstraZeneca (40%), Johnson & Johnson (J&J) (30%), Moderna, Pfizer, and Sputnik V at 10% each; with primary schedule completed by second half of 2021 (Scenario 1); AstraZeneca (30%), J&J (40%), Moderna, Pfizer, and Sputnik V at 10% each with primary schedule completed by first half of 2022 (Scenario 2); and equal distribution (20%) among AstraZeneca, J&J, Moderna, Pfizer, and Sputnik V with primary schedule completed by second half of 2022 (Scenario 3). Results: The estimated total cost of COVID-19 vaccination ranges between $348.7 and $436.1 million for the target population of 17.5 million. These translate into per person completed primary schedule cost of $20.9–$26.2 and per dose (including vaccine cost) of $10.5–$13.1. Again, per person completed primary schedule excluding vaccine cost was $4.5 and $4.6, thus per dose excluding vaccine also ranged from $2.2 – $2.3. The main cost driver was vaccine doses, including shipping, which accounts for between 78% and 83% of total cost. Further, an estimated 8,437–10,247 vaccinators (non-FTEs) would be required during 2021–2022 to vaccinate using a mix of delivery strategies, accounting for 8–10% of total cost. Conclusion: These findings provide the estimates to inform resource mobilization efforts by government and other partners.

Original languageEnglish
Pages (from-to)1879-1887
Number of pages9
JournalVaccine
Volume40
Issue number12
DOIs
Publication statusPublished - 15 Mar 2022

Keywords

  • COVID-19 vaccine
  • CVIC tool
  • Costs
  • Ghana

Fingerprint

Dive into the research topics of 'Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool'. Together they form a unique fingerprint.

Cite this